Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02268617 · ClinicalTrials.gov registry record · NA
Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington's Disease
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02268617: Completed NA study, sponsored by Ohio State University.
NCT02268617 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02268617, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Individuals with Dementia with Lewy Bodies (DLB) and Huntington's disease (HD) experience balance and walking problems that lead to falls. Treadmill walking has demonstrated improvements in balance and walking and fall risk in individuals with Parkinson's disease (PD), suggesting that it may be beneficial for individuals with DLB and HD. In PD subjects, changes in gait parameters have been noted after only one treadmill training session. The investigators propose a pilot study to investigate the safety, feasibility, and utility to improve mobility and fall risk of a single session of treadmill walking in individuals with DLB and HD.
Primary Outcome
Blood pressure, heart rate, and rating of perceived exertion will be measured before, during, and after treadmill walking.
Interventions
- OTHER Treadmill Walking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02268617 record still lists
NCT02268617 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Treadmill Walking is the first listed.
NCT02268617 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02268617 about?
NCT02268617 is a clinical study titled "Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington's Disease". Individuals with Dementia with Lewy Bodies (DLB) and Huntington's disease (HD) experience balance and walking problems that lead to falls. Treadmill walking has demonstrated improvements in balance and walking and fall risk in individuals with Parkinson's disease (PD), suggesting that it may be bene...
What is the current status of trial NCT02268617?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2013-02. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02268617?
The interventions under investigation include: Treadmill Walking (OTHER).
Who is sponsoring clinical trial NCT02268617?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02268617's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia